ARTICLE | Distillery Therapeutics
Agonizing RARG to reduce doxorubicin-induced cardiotoxicity
October 1, 2021 5:20 AM UTC
DISEASE CATEGORY: Cardiovascular
INDICATION: Organ damage...
BCIQ Target Profiles
DISEASE CATEGORY: Cardiovascular
INDICATION: Organ damage...
BCIQ Target Profiles
BCIQ Target Profiles